• BullFrog AI expects its strengthened balance sheet to support strategic priorities into late 2027.
• Strategic channel partners are expected to drive revenue growth in 2026 as the business shifts toward commercialization and enterprise adoption.
• Its first commercial agreement with a top-five pharmaceutical company, signed in the first quarter of 2026, supports potential scalable revenue growth.
• Lean operations are expected to support high operating leverage and profitable growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BullFrog AI Holdings Inc. published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.